UPDF AI

Medication-overuse headache: risk factors, pathophysiology and management

H. Diener,D. Holle,K. Solbach,C. Gaul

2016 · DOI: 10.1038/nrneurol.2016.124
Nature Reviews Neurology · 234 Zitierungen

TLDR

In all patients with MOH, relapse rates can be reduced by patient education and care in the follow-up period, and the success rate of treatment is around 50–70%, although patients whose MOH is associated with opioid overuse have higher relapse rates.